
Do Options Traders Know Something About Agilent Technologies Stock We Don't?
Investors need to pay close attention to Agilent Technologies stock based on the movements in the options market lately.
Predicted Price is the pryogiTM prediction of where the price is going in next 3-4 quarters. There may be a revision of the predicted price every 3 months from the date of publication of the first predicted price of the stock. Price on Report Date is the price of the stock on the day prediction was published by pryogiTM. Current price shows the current price of the stock.
Margin of error shows range the price will end up in dollars either above or below the predicted price. Margin of error percentage shows the price will end up in percentage either above or below the predicted price.
Expected Returns from report date shows the returns (positive or negative) from published prediction date if you bought the stock on report date. Expected Returns from today shows the returns from today if you buy the stock today. A positive expected returns indicates a profit you will make, a negative expected return indicates a loss you will make if you buy the stock. There are different strategies to apply in the stock market for profit and loss, pryogiTM will publish such strategies in the future to help you.
PryogiTM meter shows you predicted price, price on the date this prediction was published(report date) and price of the stock today on a price scale. This indicates if the stock price is moving towards or away from the predicted price
PryogiTM performance chart shows actual movement of stock price from prediction published date(report date) and if the price is moving towards or away from predicted price
Investors need to pay close attention to Agilent Technologies stock based on the movements in the options market lately.
The Benzinga Stock Whisper Index highlights five stocks each week seeing more interest from readers than normal. Tariffs could impact one of the company's on the list in their next financial results. Geopolitical tensions, Fed uncertainty, and fast-moving headlines are driving July volatility.
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Delray Beach, FL, June 27, 2025 ( GLOBE NEWSWIRE ) -- The global laboratory information management system market, valued at US$2.54 billion in 2024, stood at US$2.88 billion in 2025 and is projected to advance at a resilient CAGR of 12.5% from 2025 to 2030, culminating in a forecasted valuation ...
CAMBRIDGE, Mass., June 25, 2025 ( GLOBE NEWSWIRE ) -- Arbor Biotechnologies™, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the appointment of Mikael Dolsten, M.D., Ph.D., to its Board of Directors.
Agilent Technologies's A short percent of float has fallen 5.17% since its last report. The company recently reported that it has 4.14 million shares sold short, which is 1.65% of all regular shares that are available for trading.
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
NEW YORK and PARIS, June 18, 2025 ( GLOBE NEWSWIRE ) -- Rarecells, Inc., a leader in liquid biopsy technology, is pleased to announce the appointment of Dr. Rita Shaknovich to its Scientific Advisory Board. Dr. Shaknovich brings over 20 years of leadership experience across private industry and ...
Delray Beach, FL, June 11, 2025 ( GLOBE NEWSWIRE ) -- The global genomics market, valued at US$42.4 billion in 2023, stood at US$42.6 billion in 2024 and is projected to advance at a resilient CAGR of 9.4% from 2024 to 2029, culminating in a forecasted valuation of US$66.8 billion by the end of ...
Explore how Agilent's (A) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
A's second-quarter fiscal 2025 results benefit from strong LC & services, but margin contraction raises investor concerns.
U.S. stocks were mostly higher, with the Nasdaq Composite gaining around 100 points on Thursday. Shares of Veeva Systems Inc. VEEV rose sharply during Thursday's session following strong quarterly results. The company reported adjusted earnings per share of $1.97, beating the analyst consensus ...
Q2 adjusted EPS rose to $1.31 vs. $1.26 consensus, up from $1.22 a year ago. Agilent ups FY25 revenue forecast to $6.73 billion-$6.81 billion, from prior $6.68 billion-$6.76 billion. Unlock your all-in-one trading dashboard with real-time alerts, rankings, and stock ideas-now 60% off for ...
Agilent (A) delivered earnings and revenue surprises of 3.97% and 2.64%, respectively, for the quarter ended April 2025. Do the numbers hold clues to what lies ahead for the stock?
Judy Brown, Board Member at Agilent Technologies A, reported an insider buy on May 23, according to a new SEC filing. What Happened: Brown made a significant move by purchasing 1,677 shares of Agilent Technologies as reported in a Form 4 filing with the U.S. Securities and Exchange Commission.
Pascal Soriot, Director at Agilent Technologies A, reported an insider buy on May 23, according to a new SEC filing. What Happened: Soriot made a significant move by purchasing 1,677 shares of Agilent Technologies as reported in a Form 4 filing with the U.S. Securities and Exchange Commission.
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Agilent (A), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended April 2025.
US & Canada, May 19, 2025 ( GLOBE NEWSWIRE ) -- According to a new comprehensive report from The Insight Partners, the global digital PCR and real-time PCR market is witnessing substantial growth with the surging incidence of genetic and infectious diseases and rising investments in gene ...
Sanara MedTech (SMTI) delivered earnings and revenue surprises of -32.26% and 5.32%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Agilent Technologies's A short percent of float has risen 17.01% since its last report. The company recently reported that it has 4.32 million shares sold short, which is 1.72% of all regular shares that are available for trading.
Zimmer (ZBH) delivered earnings and revenue surprises of 2.84% and 0.88%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Agilent (A) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
SYK's first-quarter 2025 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued to hurt margins.
DexCom Q1 results are likely to reflect strong growth on the back of coverage by two large PBMs and Stelo traction, driving momentum and market expansion in 2025.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Baxter's first-quarter results are likely to reflect the favorable impact of kidney care sales. Growth in infusion therapies, pharmaceuticals and patient support systems to continue.
Investors need to pay close attention to A stock based on the movements in the options market lately.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Boston, April 04, 2025 ( GLOBE NEWSWIRE ) -- According to the latest study from BCC Research, "Bioprocess Optimization and Digital Bio-manufacturing: Global Markets" is expected to grow from $24.3 billion in 2024 to $39.6 billion by the end of 2029 at a compound annual growth rate ( CAGR ) of ...
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Proscia is rewiring pathology to speed up the development of targeted therapies, accelerate diagnosis, and match more patients with the best course of treatment Funding led by global software investor Insight Partners comes as the surge in cancer cases compounds the impact of the shrinking ...
Disclosed in the latest SEC filing, a significant insider purchase on March 18, involves Mala Anand, Director at Agilent Technologies A. What Happened: Anand's recent move, as outlined in a Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday, involves purchasing 1,819 shares ...
A notable insider purchase on March 18, was reported by Otis W Brawley, Board Member at Agilent Technologies A, based on the most recent SEC filing. What Happened: Brawley's recent move, as outlined in a Form 4 filing with the U.S.
In a recent SEC filing, it was revealed that HEIDI FIELDS, Board Member at Agilent Technologies A, made a noteworthy insider purchase on March 18,. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that FIELDS purchased 1,819 shares of Agilent ...
Rockville, MD, March 11, 2025 ( GLOBE NEWSWIRE ) -- According to Fact.MR, a market research and competitive intelligence provider, the global breast cancer diagnostics market is estimated to reach a valuation of USD 6,389 million in 2025 and is expected to grow at a CAGR of 6.9% during the ...
Wilmington, Delaware, Transparency Market Research Inc. -, March 11, 2025 ( GLOBE NEWSWIRE ) -- The laboratory consumables market in Germany, Belgium, and the Netherlands is witnessing significant growth, fueled by rising R&D investments, technological advancements, and expanding biotech ...
David Kostin, the Chief U.S. Equity Strategist of Goldman Sachs, has revised his earnings growth forecast, citing a weaker economic outlook, and highlighted a shift in market trends. What Happened: On CNBC's 'Squawk on the Street', Kostin discussed his revised earnings growth forecast and market ...
Agilent Technologies's A short percent of float has fallen 8.53% since its last report. The company recently reported that it has 2.97 million shares sold short, which is 1.18% of all regular shares that are available for trading.
Delray Beach, FL, March 04, 2025 ( GLOBE NEWSWIRE ) -- The global microbiological testing of water market is projected to grow significantly, reaching an estimated $2.3 billion by 2027 at a compound annual growth rate ( CAGR ) of 7.4%.
Rockville, MD , March 04, 2025 ( GLOBE NEWSWIRE ) -- According to Fact.MR, a market research and competitive intelligence provider, the Protection Reagents Market was valued at US$ 182.6 million in 2024 and is expected to grow at a CAGR of 5.5% during the forecast period of 2025 to 2035.
Explore how Agilent's (A) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
A's first-quarter fiscal 2025 results benefit from strong LC & services, but margin contraction raises investor concerns.
Agilent (A) delivered earnings and revenue surprises of 3.15% and 0.86%, respectively, for the quarter ended January 2025. Do the numbers hold clues to what lies ahead for the stock?
QSI's fourth-quarter performance is expected to have benefited from year-end capital spending and new product launches despite competition and stretched valuation.
Dan Loeb's Third Point cut its stake in Danaher and acquired 350,000 shares of Thermo Fisher in Q4 2024. Danaher shares fell ~10% YTD, while Thermo Fisher rose 0.66%, both underperforming the iShares U.S. Healthcare ETF.
A's fiscal first-quarter performance is likely to have been influenced by higher expenses, increased CapEx and the Lunar New Year timing shift.
Besides Wall Street's top -and-bottom-line estimates for Agilent (A), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended January 2025.